United States Acute Myeloid Leukemia Therapeutics Market Report 2016

United States Acute Myeloid Leukemia Therapeutics Market Report 2016

1 Acute Myeloid Leukemia Therapeutics Overview

1.1 Product Overview and Scope of Acute Myeloid Leukemia Therapeutics

1.2 Classification of Acute Myeloid Leukemia Therapeutics

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Acute Myeloid Leukemia Therapeutics

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Acute Myeloid Leukemia Therapeutics (2011-2021)

1.4.1 USA Acute Myeloid Leukemia Therapeutics Sales and Growth Rate (2011-2021)

1.4.2 USA Acute Myeloid Leukemia Therapeutics Revenue and Growth Rate (2011-2021)

2 USA Acute Myeloid Leukemia Therapeutics Competition by Manufacturers

2.1 USA Acute Myeloid Leukemia Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Acute Myeloid Leukemia Therapeutics Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Acute Myeloid Leukemia Therapeutics Average Price by Manufactures (2015 and 2016)

2.4 Acute Myeloid Leukemia Therapeutics Market Competitive Situation and Trends

2.4.1 Acute Myeloid Leukemia Therapeutics Market Concentration Rate

2.4.2 Acute Myeloid Leukemia Therapeutics Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Acute Myeloid Leukemia Therapeutics Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Acute Myeloid Leukemia Therapeutics Sales and Market Share by Type (2011-2016)

3.2 USA Acute Myeloid Leukemia Therapeutics Revenue and Market Share by Type (2011-2016)

3.3 USA Acute Myeloid Leukemia Therapeutics Price by Type (2011-2016)

3.4 USA Acute Myeloid Leukemia Therapeutics Sales Growth Rate by Type (2011-2016)

4 USA Acute Myeloid Leukemia Therapeutics Sales (Volume) by Application (2011-2016)

4.1 USA Acute Myeloid Leukemia Therapeutics Sales and Market Share by Application (2011-2016)

4.2 USA Acute Myeloid Leukemia Therapeutics Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Acute Myeloid Leukemia Therapeutics Manufacturers Profiles/Analysis

5.1 Bristol Myers Squibb

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Bristol Myers Squibb Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Celgene

5.2.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Celgene Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Johnson & Johnson

5.3.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Johnson & Johnson Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Pfizer

5.4.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Pfizer Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Eisai

5.5.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Eisai Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 F. Hoffmann-La Roche

5.6.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 F. Hoffmann-La Roche Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Immune Pharmaceuticals

5.7.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Immune Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Innate Pharma

5.8.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Innate Pharma Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Kanisa Pharmaceuticals

5.9.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Kanisa Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Meda

5.10.2 Acute Myeloid Leukemia Therapeutics Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Meda Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Merck Sharp & Dohme

5.12 Midas Pharmaceuticals

5.13 Neovii Biotech

5.14 Nippon Shinyaku

5.15 Novo Nordisk

5.16 Sanofi

5.17 Sunesis Pharmaceuticals

5.18 Teva Pharmaceutical

5.19 Tolero Pharmaceuticals

5.20 Cyclacel Pharmaceuticals

6 Acute Myeloid Leukemia Therapeutics Manufacturing Cost Analysis

6.1 Acute Myeloid Leukemia Therapeutics Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Acute Myeloid Leukemia Therapeutics

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Acute Myeloid Leukemia Therapeutics Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Acute Myeloid Leukemia Therapeutics Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Acute Myeloid Leukemia Therapeutics Market Forecast (2016-2021)

10.1 USA Acute Myeloid Leukemia Therapeutics Sales, Revenue Forecast (2016-2021)

10.2 USA Acute Myeloid Leukemia Therapeutics Sales Forecast by Type (2016-2021)

10.3 USA Acute Myeloid Leukemia Therapeutics Sales Forecast by Application (2016-2021)

10.4 Acute Myeloid Leukemia Therapeutics Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Acute Myeloid Leukemia Therapeutics

Table Classification of Acute Myeloid Leukemia Therapeutics

Figure USA Sales Market Share of Acute Myeloid Leukemia Therapeutics by Type in 2015

Table Application of Acute Myeloid Leukemia Therapeutics

Figure USA Sales Market Share of Acute Myeloid Leukemia Therapeutics by Application in 2015

Figure USA Acute Myeloid Leukemia Therapeutics Sales and Growth Rate (2011-2021)

Figure USA Acute Myeloid Leukemia Therapeutics Revenue and Growth Rate (2011-2021)

Table USA Acute Myeloid Leukemia Therapeutics Sales of Key Manufacturers (2015 and 2016)

Table USA Acute Myeloid Leukemia Therapeutics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Acute Myeloid Leukemia Therapeutics Sales Share by Manufacturers

Figure 2016 Acute Myeloid Leukemia Therapeutics Sales Share by Manufacturers

Table USA Acute Myeloid Leukemia Therapeutics Revenue by Manufacturers (2015 and 2016)

Table USA Acute Myeloid Leukemia Therapeutics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Acute Myeloid Leukemia Therapeutics Revenue Share by Manufacturers

Table 2016 USA Acute Myeloid Leukemia Therapeutics Revenue Share by Manufacturers

Table USA Market Acute Myeloid Leukemia Therapeutics Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Acute Myeloid Leukemia Therapeutics Average Price of Key Manufacturers in 2015

Figure Acute Myeloid Leukemia Therapeutics Market Share of Top 3 Manufacturers

Figure Acute Myeloid Leukemia Therapeutics Market Share of Top 5 Manufacturers

Table USA Acute Myeloid Leukemia Therapeutics Sales by Type (2011-2016)

Table USA Acute Myeloid Leukemia Therapeutics Sales Share by Type (2011-2016)

Figure USA Acute Myeloid Leukemia Therapeutics Sales Market Share by Type in 2015

Table USA Acute Myeloid Leukemia Therapeutics Revenue and Market Share by Type (2011-2016)

Table USA Acute Myeloid Leukemia Therapeutics Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Acute Myeloid Leukemia Therapeutics by Type (2011-2016)

Table USA Acute Myeloid Leukemia Therapeutics Price by Type (2011-2016)

Figure USA Acute Myeloid Leukemia Therapeutics Sales Growth Rate by Type (2011-2016)

Table USA Acute Myeloid Leukemia Therapeutics Sales by Application (2011-2016)

Table USA Acute Myeloid Leukemia Therapeutics Sales Market Share by Application (2011-2016)

Figure USA Acute Myeloid Leukemia Therapeutics Sales Market Share by Application in 2015

Table USA Acute Myeloid Leukemia Therapeutics Sales Growth Rate by Application (2011-2016)

Figure USA Acute Myeloid Leukemia Therapeutics Sales Growth Rate by Application (2011-2016)

Table Bristol Myers Squibb Basic Information List

Table Bristol Myers Squibb Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol Myers Squibb Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Celgene Basic Information List

Table Celgene Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celgene Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Eisai Basic Information List

Table Eisai Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eisai Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Basic Information List

Table F. Hoffmann-La Roche Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Immune Pharmaceuticals Basic Information List

Table Immune Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Immune Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Innate Pharma Basic Information List

Table Innate Pharma Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Innate Pharma Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Kanisa Pharmaceuticals Basic Information List

Table Kanisa Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kanisa Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Meda Basic Information List

Table Meda Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Meda Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Merck Sharp & Dohme Basic Information List

Table Merck Sharp & Dohme Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Sharp & Dohme Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Midas Pharmaceuticals Basic Information List

Table Midas Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Midas Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Neovii Biotech Basic Information List

Table Neovii Biotech Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neovii Biotech Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Nippon Shinyaku Basic Information List

Table Nippon Shinyaku Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nippon Shinyaku Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Sunesis Pharmaceuticals Basic Information List

Table Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Teva Pharmaceutical Basic Information List

Table Teva Pharmaceutical Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Pharmaceutical Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Tolero Pharmaceuticals Basic Information List

Table Tolero Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Tolero Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Cyclacel Pharmaceuticals Basic Information List

Table Cyclacel Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cyclacel Pharmaceuticals Acute Myeloid Leukemia Therapeutics Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Acute Myeloid Leukemia Therapeutics

Figure Manufacturing Process Analysis of Acute Myeloid Leukemia Therapeutics

Figure Acute Myeloid Leukemia Therapeutics Industrial Chain Analysis

Table Raw Materials Sources of Acute Myeloid Leukemia Therapeutics Major Manufacturers in 2015

Table Major Buyers of Acute Myeloid Leukemia Therapeutics

Table Distributors/Traders List

Figure USA Acute Myeloid Leukemia Therapeutics Production and Growth Rate Forecast (2016-2021)

Figure USA Acute Myeloid Leukemia Therapeutics Revenue and Growth Rate Forecast (2016-2021)

Table USA Acute Myeloid Leukemia Therapeutics Production Forecast by Type (2016-2021)

Table USA Acute Myeloid Leukemia Therapeutics Consumption Forecast by Application (2016-2021)